International
The Morning Science

What science found today

‹
 

Research

A shared molecular weakness in glioblastoma tumor cells may offer a new treatment target

Medical Xpress ·

A shared molecular weakness in glioblastoma tumor cells may offer a new treatment target

The Brief

  • Researchers at the Icahn School of Medicine at Mount Sinai identified a molecular trait shared across glioblastoma tumor cells.
  • The trait resembles one used by immature cells during brain development.
  • The finding may reveal a target for future glioblastoma treatments, but no treatment is described yet.

Why it matters

Glioblastoma is an aggressive adult brain cancer with limited treatment options, so a shared molecular weakness could point researchers toward new drug targets.

Who’s affected

  • cancer researchers and neuro-oncology scientists
  • patients with glioblastoma and their families

Researchers at the Icahn School of Medicine at Mount Sinai have identified a shared molecular trait in glioblastoma, an aggressive brain cancer in adults. It resembles one used by immature cells during brain development and may reveal a target for future treatments.

How do you feel about this?

0 Comments

    A shared molecular weakness in glioblastoma tumor cells may offer a new treatment target – The Morning Science